Power DG - Search Results

1

Genetic variations in angiogenesis pathway genes associated with clinical outcome in localized gastric adenocarcinoma.

Lurje G, Husain H, Power DG, Yang D, Groshen S, Pohl A, Zhang W, Ning Y, Manegold PC, El-Khoueiry A, Iqbal S, Tang LH, Shah MA, Lenz HJ. Lurje G, et al. Among authors: power dg. Ann Oncol. 2010 Jan;21(1):78-86. doi: 10.1093/annonc/mdp280. Epub 2009 Jul 21. Ann Oncol. 2010. PMID: 19622587 Free PMC article.

2

GRP78 promoter polymorphism rs391957 as potential predictor for clinical outcome in gastric and colorectal cancer patients.

Winder T, Bohanes P, Zhang W, Yang D, Power DG, Ning Y, Gerger A, Wilson PM, Tang LH, Shah M, Lee AS, Lenz HJ. Winder T, et al. Among authors: power dg. Ann Oncol. 2011 Nov;22(11):2431-2439. doi: 10.1093/annonc/mdq771. Epub 2011 Mar 7. Ann Oncol. 2011. PMID: 21382870 Free PMC article.

3

An individual coding polymorphism and the haplotype of the SPARC gene predict gastric cancer recurrence.

Winder T, Wilson PM, Yang D, Zhang W, Ning Y, Power DG, Bohanes P, Gerger A, Tang LH, Shah M, Lenz HJ. Winder T, et al. Among authors: power dg. Pharmacogenomics J. 2013 Aug;13(4):342-8. doi: 10.1038/tpj.2012.11. Epub 2012 Apr 10. Pharmacogenomics J. 2013. PMID: 22491017

4

Germline polymorphisms in genes involved in the CD44 signaling pathway are associated with clinical outcome in localized gastric adenocarcinoma.

Winder T, Ning Y, Yang D, Zhang W, Power DG, Bohanes P, Gerger A, Wilson PM, Lurje G, Tang LH, Shah M, Lenz HJ. Winder T, et al. Among authors: power dg. Int J Cancer. 2011 Sep 1;129(5):1096-104. doi: 10.1002/ijc.25787. Epub 2011 Feb 11. Int J Cancer. 2011. PMID: 21105049 Free PMC article.

5

Advanced gastric cancer--slow but steady progress.

Power DG, Kelsen DP, Shah MA. Power DG, et al. Cancer Treat Rev. 2010 Aug;36(5):384-92. doi: 10.1016/j.ctrv.2010.01.005. Epub 2010 Feb 21. Cancer Treat Rev. 2010. PMID: 20176443 Review.

6

A multicenter, phase II study of bortezomib (PS-341) in patients with unresectable or metastatic gastric and gastroesophageal junction adenocarcinoma.

Shah MA, Power DG, Kindler HL, Holen KD, Kemeny MM, Ilson DH, Tang L, Capanu M, Wright JJ, Kelsen DP. Shah MA, et al. Among authors: power dg. Invest New Drugs. 2011 Dec;29(6):1475-81. doi: 10.1007/s10637-010-9474-7. Epub 2010 Jun 25. Invest New Drugs. 2011. PMID: 20574790 Clinical Trial.

7

Endoscopic ultrasound can improve the selection for laparoscopy in patients with localized gastric cancer.

Power DG, Schattner MA, Gerdes H, Brenner B, Markowitz AJ, Capanu M, Coit DG, Brennan M, Kelsen DP, Shah MA. Power DG, et al. J Am Coll Surg. 2009 Feb;208(2):173-8. doi: 10.1016/j.jamcollsurg.2008.10.022. Epub 2008 Dec 18. J Am Coll Surg. 2009. PMID: 19228527

8

The Quality of Quality-of-Life and Cost-Effectiveness Analyses.

Power DG, Kelsen DP, Shah MA. Power DG, et al. Gastrointest Cancer Res. 2008 Mar;2(2):94-5. Gastrointest Cancer Res. 2008. PMID: 19259301 Free PMC article. No abstract available.

9

High-grade neuroendocrine carcinoma of the colon, long-term survival in advanced disease.

Power DG, Asmis TR, Tang LH, Brown K, Kemeny NE. Power DG, et al. Med Oncol. 2011 Dec;28 Suppl 1:S169-74. doi: 10.1007/s12032-010-9674-1. Epub 2010 Sep 14. Med Oncol. 2011. PMID: 20839076 Review.

10

Safety and efficacy of panitumumab following cetuximab: retrospective review of the Memorial Sloan-Kettering experience.

Power DG, Shah MA, Asmis TR, Garcia JJ, Kemeny NE. Power DG, et al. Invest New Drugs. 2010 Jun;28(3):353-60. doi: 10.1007/s10637-009-9268-y. Epub 2009 May 26. Invest New Drugs. 2010. PMID: 19468688

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

141 results

Search Page

Filters